US 9944918
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
granted A61KA61K38/00
Quick answer
US patent 9944918 (Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00